Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis.

Subjects

Subjects :

CD4-Positive T-Lymphocytes physiology
Cells, Cultured
Chemotaxis drug effects
Humans
CD4-Positive T-Lymphocytes drug effects
Chemokine CCL17 immunology
Dermatitis, Atopic immunology
Histamine Antagonists pharmacology
Olopatadine Hydrochloride pharmacology

Details

Language :

English

ISSN :

1440-1592

Volume :

64

Issue :

2

Database :

MEDLINE

Journal :

Allergology international : official journal of the Japanese Society of Allergology

Publication Type :

Editorial & Opinion

Accession number :

25838101

Full Text :

https://doi.org/10.1016/j.alit.2014.10.008